Summary | One of the highest profile cases in a recent series
of probes against multinationals in China has reached an
emphatic but reasonably just conclusion, with word that Beijing
has fined British drugmaker GlaxoSmithKline (London: GSK)
nearly half a billion dollars and handed several of its top
local executives suspended jail sentences. I was never a ...
of probes against multinationals in China has reached an
emphatic but reasonably just conclusion, with word that Beijing
has fined British drugmaker GlaxoSmithKline (London: GSK)
nearly half a billion dollars and handed several of its top
local executives suspended jail sentences. I was never a ...
youngchinabiz.com | 06 December 2015